Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / @xirurgi_2025 / @xirurgi_2025 - 566 - файл

.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
24 Мб
Скачать
25 Dumping Syndrome
https://t.me/medicina_free
3. Hormonal changes: Alterations in gastrointestinal hormone levels have long been recognized in dumping syndrome. Hyperosmolar, high volume chyme resulting from rapid gas­tric emptying increases gastrointestinal hormone secretion to supraphysiologic levels [5]. Of the many hormonal abnormali­ties demonstrated, vasoactive intestinal peptide (VIP) and serotonin appears to have prominent roles in dumping syn­drome pathophysiology [6]. VIP increases splanchnic blood ow, intestinal contractions, and secretion of electrolytes and water into the intestinal lumen. Similarly, serotonin causes splanchnic vasodilation. Oversecretion of these hormones may contribute to rapid transit and uid shifts. Bradykinin has vasodilatory effects and increases vascular permeability [7]. An exaggerated bradykinin response can increase uid shifts into peripheral vascular tissues, which may contribute to the ushing seen in some patients with dumping syndrome. Norepinephrine levels have also been found to be elevated in dumping syndrome. This may contribute to early sympathetic vasomotor symptoms including tachycardia and sweating [8]. Finally, insulinotropic hormones may be major drivers of late dumping syndrome, which is characterized by delayed hypo­glycemia in response to a food bolus. An exaggerated secre­tion of glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) in response to hyperosmolar chyme is seen in dumping syndrome [9]. This leads to an increase in insulin secretion and inhibition of glucagon, subse­quently causing hypoglycemia.
349
Epidemiology andEtiology
Dumping syndrome can be caused by surgical and nonsurgical eti­ologies. Up to 50% of gastric operations can cause rapid gastric emptying, albeit with different rates of symptoms severe enough to warrant work-up and treatment for dumping syndrome [10]. In adults, Roux-en-Y gastric bypass is the most common cause of sur-
350
https://t.me/medicina_free
gical dumping syndrome [11]. In the pediatric population, dumping syndrome is frequently secondary to Nissen fundoplication [12].
Gastric operations cause dumping syndrome by increasing the rate of chyme transit from the stomach into the intestines [2]. In normal gastric physiology, the antrum and pylorus limit gastric emptying, and the fundus acts as a reservoir for the food bolus. Roux-en-Y gastric bypass can cause dumping syndrome due to a small gastric reservoir and bypassing of the pyloric sphincter. Sleeve gastrectomy, although less frequently, can also cause dumping syndrome due to decreased gastric volume and increased emptying times. Nissen fundoplication can disrupt the reservoir function of the stomach due to decreased fundus volume to accommodate a food bolus. Vagus transections, on the other hand, can have mixed effects on gastric emptying. In patients with an intact pylorus, gastric emptying may be delayed after vagal tran­section due to a blunted pyloric relaxation. However, vagal reexes also maintain receptive gastric relaxation following ingestion of a food bolus and inhibition of gastric emptying in response to intestinal stretch. Loss of these arcs can promote rapid gastric emptying.
Nonsurgical causes of dumping syndrome are overall less common. Although early diabetes typically causes gastroparesis, patients with long-standing diabetes sometimes experience dump­ing syndrome [13]. In a subgroup of patients, the onset of dump­ing syndrome follows an episode of gastroenteritis. This is likely related to duodenal mucosal damage and the subsequent altera­tion in duodenal receptors. Finally, there is an idiopathic form of dumping syndrome. In these patients, vagal function may be impaired, resulting in decreased gastric accommodation [5].
B. Kahramangil et al.
Clinical Presentation
Dumping syndrome has two distinct forms based on the constel­lation of symptoms and timing of their onset after a meal [2] (Table25.1). Early dumping syndrome occurs within 30min of a meal and is characterized by systemic and abdominal symptoms. Systemic symptoms include fatigue, lightheadedness, tachycar-
25 Dumping Syndrome
https://t.me/medicina_free
Table 25.1 Clinical presentations of early and late dumping syndrome
Early dumping syndrome Late dumping syndrome
Onset: Within 30min of a meal Onset: 1–3h after a meal Driving physiology: Hyperosmolar
chyme and uid shifts Systemic symptoms Systemic signs Palpitations Sweating Lightheadedness Altered level of consciousness Fatigue Lightheadedness Headache Hypotension Biochemical features Abdominal symptoms Reactive hypoglycemia Early satiety Epigastric pain or fullness Diarrhea Nausea Abdominal cramps
Driving physiology: Reactive hypoglycemia
351
dia, ushing or pallor, sweating, and in severe cases, syncope. Accompanying gastrointestinal symptoms include early satiety, epigastric pain or fullness sensation, diarrhea, abdominal cramps, and nausea. Early dumping syndrome is the most common pre­sentation. The second form is late dumping syndrome. The symp­toms in this form typically manifest 1–3 h after ingestion of a meal and include sweating and lightheadedness in the setting of hypoglycemia, and in severe cases, altered level of consciousness. It is possible to have concurrent early and late dumping syndrome [14]. Severe, long-standing dumping syndrome can lead to protein- energy malnutrition. Other long-term complications include depression, anxiety, and avoidance of social interactions involving eating.
Diagnosis
The diagnosis of dumping syndrome is made with the demonstra­tion of rapid gastric emptying in the presence of appropriate symptoms. Gastric scintigraphy is the gold standard test for gas-
352
https://t.me/medicina_free
tric emptying, while oral glucose challenge may help demonstrate the maladaptive response to a food bolus. Esophagogastroduode­noscopy, colonoscopy, and stool analysis can be used to rule out other differential diagnoses.
B. Kahramangil et al.
Clinical Evaluation andDiagnostic Modalities
Clinical evaluation for dumping syndrome starts with a thorough history and physical examination. Suggestive signs and symp­toms include abdominal fullness, nausea, pallor, palpitations, weakness, and lightheadedness. Severe cases can cause altered mental status and syncope.
Demonstration of rapid gastric emptying: Radionuclide
gastric scintigraphy is the gold standard test for demonstration
of rapid gastric emptying. Standard meal for the test consists of
a 250-calorie egg-substitute labeled with 99mTc, 120mL of
water, and two slices of whole wheat bread [15]. Images are
taken immediately after ingestion, at 30min, and at 1 h, fol-
lowed by hourly images up to 4h after meal. In each image,
gastric retention is calculated based on the percentage of radio-
isotopes remaining in the stomach. <35% retention at 1h is
diagnostic for rapid gastric emptying. In late dumping syn-
drome, <20% retention at 2h is typical.
Oral glucose challenge test: Oral glucose challenge test can
be useful to conrm the diagnosis of dumping syndrome.
Patients ingest 50g of glucose after 10h of overnight fasting
[16]. Pulse and blood pressure are monitored at baseline, dur-
ing ingestion and after ingestion. Blood glucose and hemato-
crit can also be measured at these time points and repeated at
30-min intervals. An increase in heart rate of at least 10 beats
per minute is considered positive. A 3% increase in hematocrit
within the rst 30min after ingestion is compatible with early
dumping syndrome. Glucose level<60mg/dL at 2–3h after
ingestion indicates late dumping syndrome.
25 Dumping Syndrome
https://t.me/medicina_free
353
Treatment
Treatment of dumping syndrome starts with lifestyle and dietary modications. If the symptoms persist despite these changes, pharmacologic treatment is the next step. Surgical procedures are reserved for most severe cases, where symptoms cannot be con­trolled by any other means (Table25.2).
Dietary modications: Dietary modications are the rst line of treatment for dumping syndrome. Patients should ingest smaller but more frequent meals, limit carbohydrate intake, and preferentially eat complex over simple carbohydrates [17]. Lying down after a meal and ingesting solids and liquids sepa­rately can also help, as uids are likely to increase gastric emp­tying. Increasing dietary ber may slow down gastric emptying, helping avoid hypoglycemia in late dumping syndrome, and proteins can provide additional calories without worsening symptoms. Despite low patient compliance due to poor taste, guar gum and pectin are useful dietary adjuncts [18]. Both supplements work by increasing the viscosity of food bolus and subsequently help delay gastric emptying.
Table 25.2 Treatment options for dumping syndrome
Dietary modications
Ingestion of smaller but more frequent meals
Limited carbohydrate intake Tincture of opium Roux-en-Y gastric
Preferential ingestion of complex carbohydrates
Separation of liquid and solid meals
Increased dietary ber GLP-1 agonists Increased protein intake Guar gum and pectin
Pharmacologic modications Surgical treatment
Loperamide Roux-en-Y gastric
bypass reversal
bypass revision
Acarbose Continuous enteral
feeding
Octreotide
354
https://t.me/medicina_free
B. Kahramangil et al.
Pharmacologic treatment: Antimotility drugs can be useful to treat diarrhea associated with dumping syndrome. Loper­amide, a gut opioid receptor agonist, and tincture of opium can be used to decrease stool liquidity [19]. Anticholinergic agents can also improve dumping syndrome-related symptoms. They have antidiarrheal effects, slow gastric emptying, and decreased gastrointestinal cramps. Acarbose can be used to prevent hypo­glycemia in late dumping syndrome. It is an alpha glycosidase inhibitor, which inhibits the digestion of polysaccharides into monosaccharides [20]. Decreasing carbohydrate absorption can help mitigate the maladaptive insulin and glucagon-like peptide 1 secretion seen in late dumping syndrome. When all other pharmaceutical options fail, octreotide can be tried. Octreotide is a somatostatin analog, which slows gastric emp­tying and decreases splanchnic blood ow [21]. Furthermore, it inhibits the secretion of intestinal hormones including vaso­active intestinal peptide, insulin, and serotonin. Octreotide improves the symptoms of both early and late dumping syn­drome. More recently, GLP-1 agonists have been successfully utilized in the management of late dumping syndrome and hypoglycemia after gastric bypass surgery.
Surgical treatment: Surgery is the last resort for patients who continue to be severely symptomatic despite dietary modica­tions and maximal pharmacologic treatment. When under­taken, surgical treatment is usually directed at the underlying anatomic abnormality causing dumping syndrome.
Roux-en-Y gastric bypass reversal: In most cases, dump-
ing syndrome following Roux-en-Y gastric bypass can be adequately controlled with dietary modications and phar­macologic treatment. However, refractory dumping syn­drome, especially in the setting of hypoglycemia, may require surgical revision. Gastric bypass reversal to normal anatomy has been proposed to help control symptoms of dumping syndrome. In 2013, Villalonga etal. reported suc­cessful laparoscopic gastric bypass reversal in a series of patients with different pathologies including refractory dumping syndrome [22]. In the six patients who underwent
25 Dumping Syndrome
https://t.me/medicina_free
surgery for dumping syndrome, a leak was observed in one patient, which was managed with laparoscopic drainage. Despite the possibility of a successful conversion to a nor­mal anatomy, weight regain remains a major concern in patients with history of obesity. To overcome this issue, Roux-en-Y gastric bypass reversal with concomitant sleeve gastrectomy has been proposed. Carter etal. analyzed the outcomes of 12 patients who underwent conversion of gas­tric bypass to sleeve gastrectomy due to various complica­tions including refractory dumping syndrome [23]. Seven major complications were observed in 4 patients including a portal vein thrombosis, postoperative bleed, pancreatic leak, pulmonary embolism, seroma, anastomotic leak, and stricture. Although effective, this is a morbid procedure and requires very careful patient selection.
Gastric pouch restriction: In some patients with Roux-
en- Y gastric bypass, refractory hypoglycemia may develop with concurrent loss of gastric restriction due to gastric pouch dilation. In this highly selected group of patients, reconstitution of gastric restriction may help improve hypo­glycemia. Different techniques described to restrict gastric pouch volume include the surgical downsizing of the pouch, silastic ring placement, and placement of an adjustable band [17]. Z’graggen etal. analyzed the outcomes of restoration of gastric restriction in 12 patients with refractory hypogly­cemia utilizing silastic ring (n= 8) and adjustable gastric band (n=4) [24]. In this series, perioperative complication rate was 8% with resolution of hypoglycemic episodes in 11 out of 12 patients.
Continuous enteral feeding: Continuous enteral feeding
through a feeding jejunostomy can be used in select patients with refractory late dumping syndrome. This eliminates the need for food ingestion and helps prevent hypoglycemia. Enteral access can be obtained by endoscopic or surgical procedures.
355
356
https://t.me/medicina_free
B. Kahramangil et al.
References
1. Gulsrud PO, Taylor IL, Watts HD, Cohen MB, Elashoff J, Meyer JH.How gastric emptying of carbohydrate affects glucose tolerance and symptoms after truncal vagotomy with pyloroplasty. Gastroenterology. 1980;78(6):1463–71.
2. Berg P, McCallum R.Dumping syndrome: a review of the current con­cepts of pathophysiology, diagnosis, and treatment. Dig Dis Sci. 2016;61(1):11–8. https://doi.org/10.1007/s10620- 015- 3839- x.
3. Aldoori MI, Qamar MI, Read AE, Williamson RC.Increased ow in the superior mesenteric artery in dumping syndrome. Br J Surg. 1985;72(5):389–90. https://doi.org/10.1002/bjs.1800720518.
4. Lipsitz LA, Ryan SM, Parker JA, Freeman R, Wei JY, Goldberger AL.Hemodynamic and autonomic nervous system responses to mixed meal ingestion in healthy young and old subjects and dysautonomic patients with postprandial hypotension. Circulation. 1993;87(2):391–
400. https://doi.org/10.1161/01.cir.87.2.391.
5. Lawaetz O, Blackburn AM, Bloom SR, Aritas Y, Ralphs DN.Gut hor­mone prole and gastric emptying in the dumping syndrome. A hypoth­esis concerning the pathogenesis. Scand J Gastroenterol. 1983;18(1):73–80. https://doi.org/10.3109/00365528309181562.
6. Sagor GR, Bryant MG, Ghatei MA, Kirk RM, Bloom SR. Release of vasoactive intestinal peptide in the dumping syndrome. Br Med J (Clin Res Ed). 1981;282(6263):507–10. https://doi.org/10.1136/
bmj.282.6263.507.
7. Macdonald JM, Webster MM Jr, Tennyson CH, Drapanas T.Serotonin and bradykinin in the dumping syndrome. Am J Surg. 1969;117(2):204–
13. https://doi.org/10.1016/0002- 9610(69)90305- 5.
8. Gebhard B, Holst JJ, Biegelmayer C, Miholic J.Postprandial GLP-1, nor­epinephrine, and reactive hypoglycemia in dumping syndrome. Dig Dis Sci. 2001;46(9):1915–23. https://doi.org/10.1023/a:1010635131228.
9. Lin HC, Neevel C, Chen PS, Suh G, Chen JH.Slowing of intestinal tran­sit by fat or peptide YY depends on beta-adrenergic pathway. Am J Physiol Gastrointest Liver Physiol. 2003;285(6):G1310–6. https://doi.
org/10.1152/ajpgi.00230.2003.
10. Davis JL, Ripley RT.Postgastrectomy syndromes and nutritional consid­erations following gastric surgery. Surg Clin North Am. 2017;97(2):277–
93. https://doi.org/10.1016/j.suc.2016.11.005.
11. Abell TL, Minocha A.Gastrointestinal complications of bariatric sur­gery: diagnosis and therapy. Am J Med Sci. 2006;331(4):214–8. https://
doi.org/10.1097/00000441- 200604000- 00008.
12. Samuk I, Afriat R, Horne T, Bistritzer T, Barr J, Vinograd I.Dumping syndrome following Nissen fundoplication, diagnosis, and treatment. J
25 Dumping Syndrome
https://t.me/medicina_free
Pediatr Gastroenterol Nutr. 1996;23(3):235–40. https://doi.
org/10.1097/00005176- 199610000- 00006.
13. Hejazi RA, Patil H, McCallum RW.Dumping syndrome: establishing cri­teria for diagnosis and identifying new etiologies. Dig Dis Sci. 2010;55(1):117–23. https://doi.org/10.1007/s10620- 009- 0939- 5.
14. Eagon JC, Miedema BW, Kelly KA.Postgastrectomy syndromes. Surg Clin North Am. 1992;72(2):445–65. https://doi.org/10.1016/s0039-
6109(16)45689- 6.
15. Tougas G, Eaker EY, Abell TL, Abrahamsson H, Boivin M, Chen J, etal. Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol. 2000;95(6):1456–62.
https://doi.org/10.1111/j.1572- 0241.2000.02076.x.
16. van der Kleij FG, Vecht J, Lamers CB, Masclee AA.Diagnostic value of dumping provocation in patients after gastric surgery. Scand J Gastroenterol. 1996;31(12):1162–6. https://doi.
org/10.3109/00365529609036905.
17. van Beek AP, Emous M, Laville M, Tack J. Dumping syndrome after esophageal, gastric or bariatric surgery: pathophysiology, diagnosis, and management. Obes Rev. 2017;18(1):68–85. https://doi.org/10.1111/
obr.12467.
18. Leeds AR, Ralphs DN, Ebied F, Metz G, Dilawari JB.Pectin in the dump­ing syndrome: reduction of symptoms and plasma volume changes. Lancet. 1981;1(8229):1075–8. https://doi.org/10.1016/s0140-
6736(81)92242- x.
19. Schiller LR. Chronic diarrhea. Curr Treat Options Gastroenterol. 2005;8(3):259–66. https://doi.org/10.1007/s11938- 005- 0018- 8.
20. De Cunto A, Barbi E, Minen F, Ventura A.Safety and efcacy of high­dose acarbose treatment for dumping syndrome. J Pediatr Gastroenterol Nutr. 2011;53(1):113–4. https://doi.org/10.1097/
MPG.0b013e31820ae6d1.
21. Hasler WL, Soudah HC, Owyang C.Mechanisms by which octreotide ameliorates symptoms in the dumping syndrome. J Pharmacol Exp Ther. 1996;277(3):1359–65.
22. Vilallonga R, van de Vrande S, Himpens J. Laparoscopic reversal of roux-en-Y gastric bypass into normal anatomy with or without sleeve gastrectomy. Surg Endosc. 2013;27(12):4640–8. https://doi.org/10.1007/
s00464- 013- 3087- 0.
23. Carter CO, Fernandez AZ, McNatt SS, Powell MS.Conversion from gas­tric bypass to sleeve gastrectomy for complications of gastric bypass. Surg Obes Relat Dis. 2016;12(3):572–6. https://doi.org/10.1016/j.
soard.2015.07.001.
24. Z'Graggen K, Guweidhi A, Steffen R, Potoczna N, Biral R, Walther F, etal. Severe recurrent hypoglycemia after gastric bypass surgery. Obes Surg. 2008;18(8):981–8. https://doi.org/10.1007/s11695- 008- 9480- 4.
357
Normal Physiology Findings
https://t.me/medicina_free
After Hiatal Hernia Repair
26
andFundoplication
RamsesA.Saavedra andEdwardAuyang
Introduction
Hiatal hernia repair and fundoplication are performed in symptom­atic patients to help provide relief from the symptoms produced by the abnormal hiatal anatomy. The goal of surgical repair is restora­tion of “normal” anatomy. This is achieved by reduction of the her­nia and recreation of a functional gastroesophageal junction (GEJ) below the level of the diaphragm. Various techniques can be used to achieve this, including Nissen, Toupet, and Dor fundoplications. Upon recreation of the normal anatomy, restoration of physiologic function is expected. There are several common studies used to assess postoperative anatomy and physiology. The studies dis­cussed here include contrasted upper gastrointestinal esophagram (UGI), computed tomography (CT) scan, esophageal manometry, pH testing, endoscopy, gastric emptying studies, and endoluminal functional imaging. Through analysis of these studies, we will clar­ify what ndings can be considered as normal and address some common variations seen after different operative techniques.
R. A. Saavedra · E. Auyang (*) Department of Surgery, University of New Mexico School of Medicine, Albuquerque, NM, USA e-mail: rasaavedra@salud.unm.edu; eauyang@salud.unm.edu
© Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) 2023 A. D. Patel et al. (eds.), The SAGES Manual of Physiologic Evaluation of Foregut Diseases,
https://doi.org/10.1007/978-3-031-39199-6_26
359
Соседние файлы в папке @xirurgi_2025